Petros Pharmaceuticals PTPI Stock
Petros Pharmaceuticals Price Chart
Petros Pharmaceuticals PTPI Financial and Trading Overview
| Petros Pharmaceuticals stock price | 0.83 USD |
| Previous Close | 2.27 USD |
| Open | 2.23 USD |
| Bid | 0 USD x 3200 |
| Ask | 0 USD x 1200 |
| Day's Range | 2.22 - 2.89 USD |
| 52 Week Range | 0.92 - 28.8 USD |
| Volume | 164.69K USD |
| Avg. Volume | 2.62M USD |
| Market Cap | 5.52M USD |
| Beta (5Y Monthly) | 1.835589 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -6.35 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PTPI Valuation Measures
| Enterprise Value | 5.97M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.91258025 |
| Price/Book (mrq) | 0.35289344 |
| Enterprise Value/Revenue | 0.987 |
| Enterprise Value/EBITDA | -0.709 |
Trading Information
Petros Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.835589 |
| 52-Week Change | -66.10% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 28.8 USD |
| 52 Week Low | 0.92 USD |
| 50-Day Moving Average | 3.39 USD |
| 200-Day Moving Average | 3.47 USD |
PTPI Share Statistics
| Avg. Volume (3 month) | 2.62M USD |
| Avg. Daily Volume (10-Days) | 79.61K USD |
| Shares Outstanding | 2.11M |
| Float | 1.48M |
| Short Ratio | 0.24 |
| % Held by Insiders | 42.73% |
| % Held by Institutions | 2.38% |
| Shares Short | 38.46K |
| Short % of Float | 2.98% |
| Short % of Shares Outstanding | 1.82% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -219.75% |
| Gross Margin | 60.82% |
| EBITDA Margin | -139.27% |
Management Effectiveness
| Return on Assets (ttm) | -19.21% |
| Return on Equity (ttm) | -83.043% |
Income Statement
| Revenue (ttm) | 6.04M USD |
| Revenue Per Share (ttm) | 2.91 USD |
| Quarterly Revenue Growth (yoy) | 2.10% |
| Gross Profit (ttm) | N/A |
| EBITDA | -8419039 USD |
| Net Income Avi to Common (ttm) | -21248496 USD |
| Diluted EPS (ttm) | -10.88 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 8.32M USD |
| Total Cash Per Share (mrq) | 3.94 USD |
| Total Debt (mrq) | 9.49M USD |
| Total Debt/Equity (mrq) | 61.44 USD |
| Current Ratio (mrq) | 2.019 |
| Book Value Per Share (mrq) | 7.396 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8269987 USD |
| Levered Free Cash Flow (ttm) | -3054435 USD |
Profile of Petros Pharmaceuticals
| Country | United States |
| State | NY |
| City | New York |
| Address | 1185 Avenue of the Americas |
| ZIP | 10036 |
| Phone | (973) 242-0005 |
| Website | https://www.petrospharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 24 |
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a novel and patented topical formulation candidate for the treatment of acute Peyronie's disease. The company offers men's health products, including vacuum erection devices, PreBoost, VenoSeal, penile injections, and urinary tract infection tests for the treatment of erectile dysfunction. Petros Pharmaceuticals, Inc. is based in New York, New York.
Q&A For Petros Pharmaceuticals Stock
What is a current PTPI stock price?
Petros Pharmaceuticals PTPI stock price today per share is 0.83 USD.
How to purchase Petros Pharmaceuticals stock?
You can buy PTPI shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Petros Pharmaceuticals?
The stock symbol or ticker of Petros Pharmaceuticals is PTPI.
Which industry does the Petros Pharmaceuticals company belong to?
The Petros Pharmaceuticals industry is Drug Manufacturers-Specialty & Generic.
How many shares does Petros Pharmaceuticals have in circulation?
The max supply of Petros Pharmaceuticals shares is 6.88M.
What is Petros Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Petros Pharmaceuticals PE Ratio is now.
What was Petros Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Petros Pharmaceuticals EPS is -6.35 USD over the trailing 12 months.
Which sector does the Petros Pharmaceuticals company belong to?
The Petros Pharmaceuticals sector is Healthcare.
Petros Pharmaceuticals PTPI included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}